AIM
MED icon

Acrospire Investment Management’s Medifast MED Stock Holding History

Acrospire Investment Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,610
Closed -$108K – 847
2017
Q2 		$108K Buy
+2,610
New +$113K 0.1% 211
2017
Q1 		– Sell
-1,700
Closed -$71K – 2372
2016
Q4 		$71K Buy
1,700
+200
+13% +$8.05K 0.03% 1163
2016
Q3 		$57K Sell
1,500
-1,100
-42% -$39.4K 0.04% 969
2016
Q2 		$87K Sell
2,600
-200
-7% -$6.45K 0.06% 582
2016
Q1 		$85K Buy
+2,800
New +$81.8K 0.06% 435

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Acrospire Investment Management's MED Position: Q3 2017 in Review

Acrospire Investment Management sold out of Medifast (MED) in Q3 2017, closing a stake of 2,610 shares — an estimated $108K sold.

Acrospire Investment Management first reported a position in MED in Q1 2016 and held it in 5 quarters. The position peaked at $108K in Q2 2017. 168 funds tracked by Wall St. Rank hold MED as of Q3 2017.

  • Acrospire Investment Management reported no remaining Medifast position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2,610 Medifast shares in Q3 2017, an estimated $108K.
  • Acrospire Investment Management first reported a position in Medifast in Q1 2016 and held it in 5 quarters.
  • Acrospire Investment Management's Medifast position peaked at $108K in Q2 2017.
  • 168 funds tracked by Wall St. Rank held Medifast as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.